1.
Pothiaraj G, Saxena S, Manoranjani M, Pitchaikani S, Saravanan K, Shakila H. Development of a recombinant construct as an immunogenic target for leptospirosis using LipL41 and molecular adjuvants. BMRAT [Internet]. 30Sep.2024 [cited 16Oct.2024];11(9):6775-8. Available from: http://home.biomedpress.org/index.php/BMRAT/article/view/921